Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q58811708
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000208.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q58811708
|
024
|
|
|
‡a
0000-0002-2364-7152
‡2
orcid
|
024
|
|
|
‡a
54385269300
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q58811708
|
100
|
0 |
|
‡a
Maria F Hughes
‡9
es
‡9
ast
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
মারিয়া এফ হিউজ
‡9
bn
|
400
|
0 |
|
‡a
Maria F Hughes
‡c
researcher ORCID ID = 0000-0002-2364-7152
‡9
en
|
400
|
0 |
|
‡a
Maria F Hughes
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's A multiple biomarker risk score for guiding clinical decisions using a decision curve approach
|
670
|
|
|
‡a
Author's Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project.
|
670
|
|
|
‡a
Author's Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study
|
670
|
|
|
‡a
Author's BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries
|
670
|
|
|
‡a
Author's Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
|
670
|
|
|
‡a
Author's Could occupational physical activity mitigate the link between moderate kidney dysfunction and coronary heart disease?
|
670
|
|
|
‡a
Author's Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts
|
670
|
|
|
‡a
Author's High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort
|
670
|
|
|
‡a
Author's Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial
|
670
|
|
|
‡a
Author's Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort
|
670
|
|
|
‡a
Author's Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)
|
670
|
|
|
‡a
Author's Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States
|
670
|
|
|
‡a
Author's Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES).
|
670
|
|
|
‡a
Author's Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
|
670
|
|
|
‡a
Author's Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium
|
670
|
|
|
‡a
Author's ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality
|
670
|
|
|
‡a
Author's Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
|
670
|
|
|
‡a
Author's The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals
|
670
|
|
|
‡a
Author's The Predictive Value of Depressive Symptoms for All-Cause Mortality: Findings From the PRIME Belfast Study Examining the Role of Inflammation and Cardiovascular Risk Markers
|
670
|
|
|
‡a
Author's Underrepresentation of sex in reporting traditional and emerging biomarkers for primary prevention of cardiovascular disease: a systematic review
|
670
|
|
|
‡a
Author's Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States
|
909
|
|
|
‡a
(orcid) 0000000223647152
‡9
1
|
909
|
|
|
‡a
(scopus) 54385269300
‡9
1
|
912
|
|
|
‡a
geneticsofbloodpressureregulationanditstargetorgansfromassociationstudiesin342415individuals
‡A
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals
‡9
1
|
919
|
|
|
‡a
predictivevalueofdepressivesymptomsforallcausemortalityfindingsfromtheprimebelfaststudyexaminingtheroleofinflammationandcardiovascularriskmarkers
‡A
The Predictive Value of Depressive Symptoms for All-Cause Mortality: Findings From the PRIME Belfast Study Examining the Role of Inflammation and Cardiovascular Risk Markers
‡9
1
|
919
|
|
|
‡a
vitamin500andmortalitymetaanalysisofindividualparticipantdatafromalargeconsortiumofcohortstudiesfromeuropeandtheunitedstates
‡A
Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States
‡9
1
|
919
|
|
|
‡a
multiplebiomarkerriskscoreforguidingclinicaldecisionsusingadecisioncurveapproach
‡A
A multiple biomarker risk score for guiding clinical decisions using a decision curve approach
‡9
1
|
919
|
|
|
‡a
alcoholicbeveragepreferenceanddiabetesincidenceacrosseuropetheconsortiumonhealthandageingnetworkofcohortsineuropeandtheunitedstateschancesproject
‡A
Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project.
‡9
1
|
919
|
|
|
‡a
associationofrepeatedlymeasuredhighsensitivityassayedtroponin1withcardiovasculardiseaseeventsinageneralpopulationfromthemorgambiomarcarestudy
‡A
Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study
‡9
1
|
919
|
|
|
‡a
biomarcarerationaleanddesignoftheeuropeanbiomarcareprojectincluding300000participantsfrom13europeancountries
‡A
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries
‡9
1
|
919
|
|
|
‡a
comparisonofcardiovascularriskfactorsineuropeanpopulationcohortsforpredictingatrialfibrillationandheartfailuretheirsubsequentonsetanddeath
‡A
Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
‡9
1
|
919
|
|
|
‡a
couldoccupationalphysicalactivitymitigatethelinkbetweenmoderatekidneydysfunctionandcoronaryheartdisease
‡A
Could occupational physical activity mitigate the link between moderate kidney dysfunction and coronary heart disease?
‡9
1
|
919
|
|
|
‡a
geneticmarkersenhancecoronaryriskpredictioninmenthemorgamprospectivecohorts
‡A
Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts
‡9
1
|
919
|
|
|
‡a
underrepresentationofsexinreportingtraditionalandemergingbiomarkersforprimarypreventionofcardiovasculardiseaseasystematicreview
‡A
Underrepresentation of sex in reporting traditional and emerging biomarkers for primary prevention of cardiovascular disease: a systematic review
‡9
1
|
919
|
|
|
‡a
highpopulationprevalenceofcardiactroponin1measuredbyahighsensitivityassayandcardiovascularriskestimationthemorgambiomarkerprojectscottishcohort
‡A
High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort
‡9
1
|
919
|
|
|
‡a
personalizedcardiometabolicresponsestoanantiinflammatorynutritioninterventioninobeseadolescentsarandomizedcontrolledcrossovertrial
‡A
Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial
‡9
1
|
919
|
|
|
‡a
predictivevalueofgalectin3forincidentcardiovasculardiseaseandheartfailureinthepopulationbasedfinrisk1997cohort
‡A
Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort
‡9
1
|
919
|
|
|
‡a
primemoverorfellowtraveller25hydroxyvitamindsseasonalvariationcardiovasculardiseaseanddeathinthescottishhearthealthextendedcohortshhec
‡A
Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)
‡9
1
|
919
|
|
|
‡a
repeatedmeasuresofbodymassindexand100reactiveproteininrelationtoallcausemortalityandcardiovasculardiseaseresultsfromtheconsortiumonhealthandageingnetworkofcohortsineuropeandtheunitedstates
‡A
Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States
‡9
1
|
919
|
|
|
‡a
repeatedmeasuresofbodymassindexand100reactiveproteininrelationtoallcausemortalityandcardiovasculardiseaseresultsfromtheconsortiumonhealthandageingnetworkofcohortsineuropeandtheunitedstateschances
‡A
Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES).
‡9
1
|
919
|
|
|
‡a
sexdifferencesandsimilaritiesinatrialfibrillationepidemiologyriskfactorsandmortalityincommunitycohortsresultsfromthebiomarcareconsortiumbiomarkerforcardiovascularriskassessmentineurope
‡A
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
‡9
1
|
919
|
|
|
‡a
sexspecificepidemiologyofheartfailureriskandmortalityineuroperesultsfromthebiomarcareconsortium
‡A
Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium
‡9
1
|
919
|
|
|
‡a
st2maynotbeausefulpredictorforincidentcardiovasculareventsheartfailureandmortality
‡A
ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality
‡9
1
|
919
|
|
|
‡a
temporalrelationsbetweenatrialfibrillationandischaemicstrokeandtheirprognosticimpactonmortality
‡A
Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
BIBSYS|1535375970044
|
996
|
|
|
‡2
ISNI|000000003357532X
|
996
|
|
|
‡2
DNB|1158192045
|
996
|
|
|
‡2
RERO|A011387898
|
996
|
|
|
‡2
LC|no2008011970
|
996
|
|
|
‡2
N6I|vtls001390746
|
996
|
|
|
‡2
ISNI|0000000040987592
|
996
|
|
|
‡2
LC|n 84052054
|
996
|
|
|
‡2
CAOONL|ncf11373020
|
996
|
|
|
‡2
LC|no2006095761
|
996
|
|
|
‡2
CAOONL|ncf10999951
|
996
|
|
|
‡2
BIBSYS|6023714
|
996
|
|
|
‡2
LC|no2004037005
|
996
|
|
|
‡2
BIBSYS|90129739
|
996
|
|
|
‡2
NSK|000156357
|
996
|
|
|
‡2
ISNI|0000000497769691
|
996
|
|
|
‡2
RERO|A009664120
|
996
|
|
|
‡2
NKC|xx0220419
|
996
|
|
|
‡2
ISNI|0000000110401981
|
996
|
|
|
‡2
JPG|500245642
|
996
|
|
|
‡2
N6I|vtls002436280
|
996
|
|
|
‡2
NTA|070184038
|
996
|
|
|
‡2
RERO|A014057216
|
996
|
|
|
‡2
W2Z|1707990471264
|
996
|
|
|
‡2
LC|no2010072657
|
996
|
|
|
‡2
LC|no2005001179
|
996
|
|
|
‡2
SUDOC|190035129
|
996
|
|
|
‡2
DNB|1089636172
|
996
|
|
|
‡2
SUDOC|125275366
|
996
|
|
|
‡2
ISNI|0000000074157810
|
996
|
|
|
‡2
B2Q|0000811139
|
996
|
|
|
‡2
SELIBR|340985
|
996
|
|
|
‡2
BNF|14155658
|
996
|
|
|
‡2
SUDOC|270350691
|
996
|
|
|
‡2
ISNI|0000000063655347
|
996
|
|
|
‡2
BNF|12307023
|
996
|
|
|
‡2
SUDOC|182710521
|
996
|
|
|
‡2
ISNI|0000000076546879
|
996
|
|
|
‡2
ISNI|0000000067147374
|
996
|
|
|
‡2
NUKAT|n 94203813
|
996
|
|
|
‡2
PLWABN|9813156686605606
|
996
|
|
|
‡2
LC|n 89673637
|
996
|
|
|
‡2
LC|no2015169166
|
996
|
|
|
‡2
LC|no2011062862
|
996
|
|
|
‡2
ISNI|0000000050285906
|
996
|
|
|
‡2
ISNI|0000000064318772
|
996
|
|
|
‡2
CAOONL|ncf11579706
|
996
|
|
|
‡2
NII|DA04966792
|
996
|
|
|
‡2
DNB|1034285874
|
996
|
|
|
‡2
DNB|1145786049
|
996
|
|
|
‡2
LC|n 84172134
|
996
|
|
|
‡2
LC|n 50029424
|
996
|
|
|
‡2
LC|n 81003621
|
996
|
|
|
‡2
ISNI|0000000036963571
|
996
|
|
|
‡2
DNB|11914767X
|
996
|
|
|
‡2
CAOONL|ncf10348210
|
996
|
|
|
‡2
SUDOC|05698801X
|
996
|
|
|
‡2
NII|DA05364070
|
996
|
|
|
‡2
ISNI|0000000062034602
|
996
|
|
|
‡2
J9U|987007357087205171
|
996
|
|
|
‡2
ISNI|0000000047670838
|
996
|
|
|
‡2
LC|no2003118604
|
996
|
|
|
‡2
ISNI|0000000497213300
|
996
|
|
|
‡2
LC|n 87148002
|
996
|
|
|
‡2
LC|n 85346689
|
996
|
|
|
‡2
ISNI|000000004916658X
|
996
|
|
|
‡2
ISNI|0000000052866472
|
996
|
|
|
‡2
J9U|987007454591705171
|
996
|
|
|
‡2
ISNI|0000000084621621
|
996
|
|
|
‡2
LC|no 90011057
|
996
|
|
|
‡2
LC|nb 90445337
|
996
|
|
|
‡2
BIBSYS|12068833
|
996
|
|
|
‡2
ISNI|0000000024661955
|
996
|
|
|
‡2
NTA|10541588X
|
996
|
|
|
‡2
NTA|284842087
|
996
|
|
|
‡2
ISNI|0000000041099044
|
996
|
|
|
‡2
NTA|074009532
|
996
|
|
|
‡2
LC|n 80149778
|
996
|
|
|
‡2
BIBSYS|90967140
|
996
|
|
|
‡2
SUDOC|057508313
|
996
|
|
|
‡2
LC|n 2006049315
|
996
|
|
|
‡2
LC|nb2018018752
|
996
|
|
|
‡2
SUDOC|031948499
|
996
|
|
|
‡2
J9U|987011910427805171
|
996
|
|
|
‡2
J9U|987007444717305171
|
996
|
|
|
‡2
DNB|1120947839
|
996
|
|
|
‡2
ISNI|0000000063362130
|
996
|
|
|
‡2
RERO|A013601984
|
996
|
|
|
‡2
LC|no2013103419
|
996
|
|
|
‡2
LC|n 2018014216
|
996
|
|
|
‡2
RERO|A003388781
|
996
|
|
|
‡2
CAOONL|ncf10013470
|
996
|
|
|
‡2
J9U|987007338244305171
|
996
|
|
|
‡2
DNB|120732776X
|
996
|
|
|
‡2
BNF|16657488
|
996
|
|
|
‡2
LC|no2024111750
|
996
|
|
|
‡2
ISNI|0000000050655946
|
996
|
|
|
‡2
LC|no2016151612
|
996
|
|
|
‡2
LC|nr 95010730
|
996
|
|
|
‡2
BAV|495_164382
|
996
|
|
|
‡2
ISNI|0000000051666962
|
996
|
|
|
‡2
NII|DA01402032
|
996
|
|
|
‡2
ISNI|0000000079240752
|
996
|
|
|
‡2
SUDOC|120985764
|
996
|
|
|
‡2
BNF|17898812
|
996
|
|
|
‡2
SUDOC|170002934
|
996
|
|
|
‡2
NTA|397735952
|
996
|
|
|
‡2
NTA|398740127
|
996
|
|
|
‡2
J9U|987007364640005171
|
996
|
|
|
‡2
ISNI|0000000075790634
|
996
|
|
|
‡2
LC|n 79145436
|
996
|
|
|
‡2
LC|no2005086241
|
996
|
|
|
‡2
JPG|500024734
|
996
|
|
|
‡2
LC|no2010014574
|
996
|
|
|
‡2
BNE|XX1506459
|
996
|
|
|
‡2
LC|no2005086244
|
996
|
|
|
‡2
LC|no2023076603
|
996
|
|
|
‡2
CAOONL|ncf10327484
|
996
|
|
|
‡2
ISNI|0000000025502905
|
996
|
|
|
‡2
NUKAT|n 97003792
|
996
|
|
|
‡2
SUDOC|168099888
|
996
|
|
|
‡2
LNB|LNC10-000347507
|
996
|
|
|
‡2
ISNI|0000000038433371
|
996
|
|
|
‡2
ISNI|0000000119213602
|
996
|
|
|
‡2
N6I|vtls002242541
|
996
|
|
|
‡2
NLA|000035494892
|
996
|
|
|
‡2
LC|n 00123982
|
996
|
|
|
‡2
BIBSYS|1707990471264
|
996
|
|
|
‡2
LC|nb2004310549
|
996
|
|
|
‡2
LC|nr2004035704
|
996
|
|
|
‡2
BNCHL|10000000000000000802856
|
996
|
|
|
‡2
DNB|1077656513
|
996
|
|
|
‡2
J9U|987007272033605171
|
996
|
|
|
‡2
LC|n 2023053816
|
996
|
|
|
‡2
ISNI|0000000387695273
|
996
|
|
|
‡2
LC|no 95002267
|
996
|
|
|
‡2
BIBSYS|90758996
|
996
|
|
|
‡2
LC|n 86816148
|
996
|
|
|
‡2
N6I|vtls000017952
|
996
|
|
|
‡2
DNB|1132154529
|
996
|
|
|
‡2
LC|n 2007180539
|
996
|
|
|
‡2
LC|no2004034248
|
996
|
|
|
‡2
LC|no 93009514
|
996
|
|
|
‡2
LC|n 84804391
|
996
|
|
|
‡2
DNB|108374858
|
996
|
|
|
‡2
LC|no2008158723
|
996
|
|
|
‡2
BIBSYS|7080693
|
996
|
|
|
‡2
LC|n 99047097
|
996
|
|
|
‡2
ISNI|0000000023625936
|
996
|
|
|
‡2
DNB|1243818107
|
996
|
|
|
‡2
LC|n 2001042372
|
996
|
|
|
‡2
ISNI|0000000493444697
|
996
|
|
|
‡2
LC|no 99010744
|
996
|
|
|
‡2
ISNI|0000000120307040
|
996
|
|
|
‡2
BIBSYS|90190153
|
996
|
|
|
‡2
ISNI|0000000116743392
|
996
|
|
|
‡2
LC|nb2001076812
|
996
|
|
|
‡2
ISNI|000000010969895X
|
996
|
|
|
‡2
CAOONL|ncf10023867
|
996
|
|
|
‡2
CAOONL|ncf10433459
|
996
|
|
|
‡2
ISNI|0000000035412356
|
996
|
|
|
‡2
LC|n 92088785
|
996
|
|
|
‡2
ISNI|000000004461884X
|
996
|
|
|
‡2
SELIBR|340984
|
996
|
|
|
‡2
LC|nr2003021770
|
996
|
|
|
‡2
LC|no 92006565
|
996
|
|
|
‡2
ISNI|0000000084684972
|
996
|
|
|
‡2
ISNI|0000000022804182
|
996
|
|
|
‡2
SKMASNL|vtls011356401
|
996
|
|
|
‡2
B2Q|0000312753
|
996
|
|
|
‡2
ISNI|0000000041631686
|
996
|
|
|
‡2
LC|n 83142760
|
996
|
|
|
‡2
LC|n 2012069680
|
996
|
|
|
‡2
DNB|1286252989
|
996
|
|
|
‡2
SUDOC|092697364
|
996
|
|
|
‡2
ISNI|0000000051683375
|
996
|
|
|
‡2
SUDOC|170284204
|
996
|
|
|
‡2
PLWABN|9810573180405606
|
996
|
|
|
‡2
ISNI|0000000385172284
|
996
|
|
|
‡2
ISNI|0000000434885281
|
996
|
|
|
‡2
LC|n 91087092
|
996
|
|
|
‡2
LC|n 87863268
|
996
|
|
|
‡2
LC|n 80118449
|
996
|
|
|
‡2
BLBNB|000425416
|
996
|
|
|
‡2
NLA|000035352021
|
996
|
|
|
‡2
N6I|vtls000047087
|
996
|
|
|
‡2
ISNI|0000000076545083
|
996
|
|
|
‡2
ISNI|0000000040322523
|
996
|
|
|
‡2
NUKAT|n 2017031876
|
996
|
|
|
‡2
BIBSYS|90317697
|
996
|
|
|
‡2
CAOONL|ncf10387105
|
996
|
|
|
‡2
DNB|132069849
|
996
|
|
|
‡2
LC|no2011062138
|
996
|
|
|
‡2
CAOONL|ncf11460516
|
996
|
|
|
‡2
ISNI|0000000044273554
|
996
|
|
|
‡2
LC|n 86063282
|
996
|
|
|
‡2
ISNI|0000000108865656
|
996
|
|
|
‡2
SUDOC|147551323
|
996
|
|
|
‡2
ISNI|0000000496947193
|
996
|
|
|
‡2
RERO|A013418136
|
996
|
|
|
‡2
CAOONL|ncf10549949
|
996
|
|
|
‡2
NTA|357966856
|
996
|
|
|
‡2
LC|n 2005051036
|
996
|
|
|
‡2
J9U|987007443728005171
|
996
|
|
|
‡2
ISNI|0000000044401800
|
996
|
|
|
‡2
ISNI|0000000044916679
|
996
|
|
|
‡2
LC|n 2007005014
|
996
|
|
|
‡2
DNB|1243592583
|
996
|
|
|
‡2
J9U|987007332989705171
|
996
|
|
|
‡2
LC|nr2002000461
|
996
|
|
|
‡2
N6I|vtls001252209
|
996
|
|
|
‡2
DNB|108050298X
|
996
|
|
|
‡2
BNF|15522043
|
996
|
|
|
‡2
LC|n 2005080986
|
996
|
|
|
‡2
LC|n 2017048845
|
996
|
|
|
‡2
LC|n 2017048843
|
996
|
|
|
‡2
ISNI|0000000457082609
|
996
|
|
|
‡2
J9U|987007301229105171
|
996
|
|
|
‡2
J9U|987009449075805171
|
996
|
|
|
‡2
ISNI|0000000033795664
|
996
|
|
|
‡2
ISNI|0000000048171838
|
996
|
|
|
‡2
LC|n 2004014172
|
996
|
|
|
‡2
LC|no 95059203
|
996
|
|
|
‡2
LC|n 97122928
|
996
|
|
|
‡2
RERO|A005835332
|
996
|
|
|
‡2
LC|n 97001635
|
996
|
|
|
‡2
CAOONL|ncf12053799
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|